U.S. Markets closed
  • S&P 500

    4,228.48
    -55.26 (-1.29%)
     
  • Dow 30

    33,706.74
    -292.30 (-0.86%)
     
  • Nasdaq

    12,705.21
    -260.08 (-2.01%)
     
  • Russell 2000

    1,957.35
    -43.38 (-2.17%)
     
  • Crude Oil

    89.91
    -0.59 (-0.65%)
     
  • Gold

    1,760.30
    -10.90 (-0.62%)
     
  • Silver

    18.97
    -0.50 (-2.56%)
     
  • EUR/USD

    1.0044
    -0.0048 (-0.4721%)
     
  • 10-Yr Bond

    2.9890
    +0.1090 (+3.78%)
     
  • Vix

    20.60
    +1.04 (+5.32%)
     
  • GBP/USD

    1.1823
    -0.0109 (-0.9163%)
     
  • USD/JPY

    136.9300
    +1.0680 (+0.7861%)
     
  • BTC-USD

    21,059.95
    -1,884.68 (-8.21%)
     
  • CMC Crypto 200

    504.88
    -36.72 (-6.78%)
     
  • FTSE 100

    7,550.37
    +8.52 (+0.11%)
     
  • Nikkei 225

    28,930.33
    -11.77 (-0.04%)
     

Novavax Outperforms Rivals After FDA Panel Backs Updated Covid Shots

·5 min read
Novavax Outperforms Rivals After FDA Panel Backs Updated Covid Shots
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Vaccine stocks rose Wednesday after a experts recommended including an omicron-fighting component in updated Covid boosters this fall.